Adaptive design is an innovative approach that allows to conduct clinical trials more efficiently (with fewer patients, in shorter terms) or to increase the likelihood of demonstrating the effect of the drug. In studies with adaptation, the possibility of modifying...
On November, 16 th , at 11:00 am, we will hold a webinar on the “Highlights of the next-in-class drugs development”. The development of pharmacologically similar agents and improved analogues of innovative drugs (next-in-class) is one of the...
Each year IPHARMA takes part in DIA (Drug Information Association) Global Conferences in Europe and the USA. During the event, participants share their views and knowledge and establish international contacts with potential partners and clients, which leads...